Reunion Neuroscience Common Stock

Reunion Neuroscience (REUN) currently reports a common stock of $110M as of March 2023. That compares with $130M in the prior-year period — down 18.8% year over year. Use the charts on this page to explore Reunion Neuroscience's common stock history and peer comparisons.

Reunion Neuroscience's common stock decreased from $130M to $110M — a 18.8% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Reunion Neuroscience reported $110M in common stock as of March 2023. That compares with $130M in the prior-year period — down 18.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Reunion Neuroscience, and consider following REUN for alerts when major investors trade the stock.

Reunion Neuroscience is classified in the Healthcare sector. On common stock, it currently shows $110M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing REUN with unrelated industries.